Insulin glargine (Hefei Tianmai)

甘精胰岛素生物类似药 (合肥天麦)

Report date: 2026/05/26 20:00:28

Base Information

Drug NameInsulin glargine (Hefei Tianmai)
Drug Alias NameN/A
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionInsulin receptor agonists
TargetsInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsDiabetes Mellitus
Approved Indications in ChinaDiabetes Mellitus
Original Approved Country/TerritoryMainland China
Original Approved Date2024/06/18
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesHefei Tianmai Biotechnology Development Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHefei Tianmai Biotechnology Development Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A